8.00
前日終値:
$7.98
開ける:
$7.77
24時間の取引高:
1.49M
Relative Volume:
0.52
時価総額:
$1.07B
収益:
$24.30M
当期純損益:
$-145.57M
株価収益率:
-6.015
EPS:
-1.33
ネットキャッシュフロー:
$-149.17M
1週間 パフォーマンス:
-4.41%
1か月 パフォーマンス:
-11.29%
6か月 パフォーマンス:
+434.02%
1年 パフォーマンス:
+122.51%
Tango Therapeutics Inc Stock (TNGX) Company Profile
TNGX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TNGX
Tango Therapeutics Inc
|
8.005 | 1.07B | 24.30M | -145.57M | -149.17M | -1.33 |
|
ARGX
Argen X Se Adr
|
918.60 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.51 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
201.62 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
363.80 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
725.87 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-19 | 開始されました | Piper Sandler | Overweight |
| 2024-07-17 | 開始されました | Jefferies | Buy |
| 2024-04-04 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-02-12 | 開始されました | Piper Sandler | Overweight |
| 2023-12-08 | 開始されました | B. Riley Securities | Buy |
| 2022-10-20 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Tango Therapeutics Inc (TNGX) 最新ニュース
B. Riley Adjusts Price Target on Tango Therapeutics to $14 From $8, Maintains Buy Rating - MarketScreener
Will Tango Therapeutics Inc. stock benefit from automation2025 Valuation Update & Safe Capital Growth Tips - newser.com
Why Tango Therapeutics Inc. stock remains on watchlistsJuly 2025 Gainers & Technical Entry and Exit Tips - newser.com
Will Tango Therapeutics Inc. stock maintain dividend yieldInsider Selling & Reliable Breakout Forecasts - newser.com
Using AI based signals to follow Tango Therapeutics Inc.2025 Macro Impact & Short-Term High Return Strategies - newser.com
Does Tango Therapeutics Inc. fit your quant trading modelMarket Growth Report & Daily Market Momentum Tracking - newser.com
Long term hold vs stop loss in Tango Therapeutics Inc.July 2025 Trade Ideas & Daily Risk Controlled Trade Plans - newser.com
Why Tango Therapeutics Inc. is moving today2025 Fundamental Recap & Daily Stock Momentum Reports - newser.com
Can Tango Therapeutics Inc. stock outperform in 2025 bull marketWeekly Profit Report & Advanced Swing Trade Entry Alerts - newser.com
How Tango Therapeutics Inc. stock performs in rising dollar environment2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
Short interest data insights for Tango Therapeutics Inc.July 2025 PostEarnings & Safe Entry Zone Tips - newser.com
Why Tango Therapeutics Inc. stock is trending among retail tradersWeekly Market Outlook & Daily Volume Surge Trade Alerts - newser.com
Will Tango Therapeutics Inc. stock attract ESG investorsMarket Rally & Daily Profit Maximizing Trade Tips - newser.com
Tango Therapeutics (TNGX): Evaluating Valuation Following Strong Revenue Growth and Doubling Share Price - Yahoo Finance
How Investors May Respond To Tango Therapeutics (TNGX) Posting First Profit on Surging Q3 Revenue - Yahoo Finance
Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference - The Manila Times
Wall Street Analysts Think Tango Therapeutics (TNGX) Could Surge 52.2%: Read This Before Placing a Bet - MSN
How to build a dashboard for Tango Therapeutics Inc. stockJuly 2025 Momentum & Free Fast Entry Momentum Trade Alerts - newser.com
How strong is Tango Therapeutics Inc. stock balance sheet2025 Biggest Moves & Weekly Stock Performance Updates - fcp.pa.gov.br
Tango Therapeutics Inc (TNGX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):